Ong F - Search Results

1

Comparison of 36 Gy, 20 Gy, or No Radiation Therapy After 6 Cycles of EBVP Chemotherapy and Complete Remission in Early-Stage Hodgkin Lymphoma Without Risk Factors: Results of the EORT-GELA H9-F Intergroup Randomized Trial.

Thomas J, Fermé C, Noordijk EM, Morschhauser F, Girinsky T, Gaillard I, Lugtenburg PJ, André M, Lybeert MLM, Stamatoullas A, Beijert M, Hélias P, Eghbali H, Gabarre J, van der Maazen RWM, Jaubert J, Bouabdallah K, Boulat O, Roesink JM, Christian B, Ong F, Bordessoule D, Tertian G, Gonzalez H, Vranovsky A, Quittet P, Tirelli U, de Jong D, Audouin J, Aleman BMP, Henry-Amar M. Thomas J, et al. Among authors: ong f. Int J Radiat Oncol Biol Phys. 2018 Apr 1;100(5):1133-1145. doi: 10.1016/j.ijrobp.2017.10.015. Epub 2017 Oct 27. Int J Radiat Oncol Biol Phys. 2018. PMID: 29229324 Clinical Trial.

2

International Prognostic Index for aggressive non-Hodgkin's lymphoma is valid for all malignancy grades.

Hermans J, Krol AD, van Groningen K, Kluin PM, Kluin-Nelemans JC, Kramer MH, Noordijk EM, Ong F, Wijermans PW. Hermans J, et al. Among authors: ong f. Blood. 1995 Aug 15;86(4):1460-3. Blood. 1995. PMID: 7632953 Free article.

3

Presenting signs and symptoms in multiple myeloma: high percentages of stage III among patients without apparent myeloma-associated symptoms.

Ong F, Hermans J, Noordijk EM, Wijermans PW, Kluin-Nelemans JC. Ong F, et al. Ann Hematol. 1995 Mar;70(3):149-52. doi: 10.1007/BF01682035. Ann Hematol. 1995. PMID: 7718643

4

Is the Durie and Salmon diagnostic classification system for plasma cell dyscrasias still the best choice? Application of three classification systems to a large population-based registry of paraproteinemia and multiple myeloma.

Ong F, Hermans J, Noordijk EM, Kluin-Nelemans JC. Ong F, et al. Ann Hematol. 1995 Jan;70(1):19-24. doi: 10.1007/BF01715377. Ann Hematol. 1995. PMID: 7827202

5

A population-based registry on paraproteinaemia in The Netherlands. Comprehensive Cancer Centre West, Leiden, The Netherlands.

Ong F, Hermans J, Noordijk EM, Wijermans PW, Seelen PJ, de Kieviet W, Gerrits WB, Kluin PM, Kluin-Nelemans JC. Ong F, et al. Br J Haematol. 1997 Dec;99(4):914-20. doi: 10.1046/j.1365-2141.1997.4943298.x. Br J Haematol. 1997. PMID: 9432042 Free article.

6

Development of a "Myeloma Risk Score" using a population-based registry on paraproteinemia and myeloma.

Ong F, Hermans J, Noordijk EM, De Kieviet W, Seelen PJ, Wijermans PW, Kluin-Nelemans JC. Ong F, et al. Leuk Lymphoma. 1997 Nov;27(5-6):495-501. doi: 10.3109/10428199709058316. Leuk Lymphoma. 1997. PMID: 9477131

7

The value of a positive margin for invasive carcinoma in breast-conservative treatment in relation to local recurrence is limited to young women only.

Jobsen JJ, van der Palen J, Ong F, Meerwaldt JH. Jobsen JJ, et al. Among authors: ong f. Int J Radiat Oncol Biol Phys. 2003 Nov 1;57(3):724-31. doi: 10.1016/s0360-3016(03)00644-8. Int J Radiat Oncol Biol Phys. 2003. PMID: 14529777

8

Effect of external boost volume in breast-conserving therapy on local control with long-term follow-up.

Jobsen JJ, van der Palen J, Ong F. Jobsen JJ, et al. Among authors: ong f. Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):115-22. doi: 10.1016/j.ijrobp.2007.09.009. Epub 2008 Jan 30. Int J Radiat Oncol Biol Phys. 2008. PMID: 18234450

9

Premature ovarian failure and fertility in long-term survivors of Hodgkin's lymphoma: a European Organisation for Research and Treatment of Cancer Lymphoma Group and Groupe d'Etude des Lymphomes de l'Adulte Cohort Study.

van der Kaaij MA, Heutte N, Meijnders P, Abeilard-Lemoisson E, Spina M, Moser EC, Allgeier A, Meulemans B, Simons AH, Lugtenburg PJ, Aleman BM, Noordijk EM, Fermé C, Thomas J, Stamatoullas A, Fruchart C, Brice P, Gaillard I, Bologna S, Ong F, Eghbali H, Doorduijn JK, Morschhauser F, Sebban C, Roesink JM, Bouteloup M, Van Hoof A, Raemaekers JM, Henry-Amar M, Kluin-Nelemans HC. van der Kaaij MA, et al. Among authors: ong f. J Clin Oncol. 2012 Jan 20;30(3):291-9. doi: 10.1200/JCO.2011.37.1989. Epub 2011 Dec 19. J Clin Oncol. 2012. PMID: 22184372

10

Sequence of radiotherapy and chemotherapy in breast cancer after breast-conserving surgery.

Jobsen JJ, van der Palen J, Brinkhuis M, Ong F, Struikmans H. Jobsen JJ, et al. Among authors: ong f. Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):e811-7. doi: 10.1016/j.ijrobp.2011.11.020. Epub 2012 Jan 31. Int J Radiat Oncol Biol Phys. 2012. PMID: 22300558

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

187 results

Search Page